21st Princeton Conference on Cerebrovascular Disease

 

May 8-10, 1998
Saint Louis, Missouri


T
he published proceedings of the 21st Princeton Conference are now available.

Cerebrovascular Disease: Momentum at the End of the Second Millennium
Editors: Dennis Choi, Ralph Dacey, Chung Hsu, William Powers
Blackwell Publishing (February 2002)
Medirect | Amazon

 

Friday, May 8, 1998


Welcome
Dennis W. Choi, MD, PhD


NIH/NINDS challenge: New opportunities and initiatives
Gerald D. Fischbach MD, and Michael D. Walker, MD


Extracranial-intracranial bypass surgery: Time for a new clinical trial?
Chairs: Ralph G. Dacey Jr. and William J. Powers

  • Ralph G. Dacey Jr., MD
    Introduction / frame
  • Robert L. Grubb Jr., MD
    Cerebral hemodynamics and stroke risk
  • Marc R. Mayberg, MD
    Surgical considerations
  • Henry J.M. Barnett, MD
    Do we need another trial?
  • William J. Powers, MD
    Interactive Discussion


Mediators and modulators of ischemic injury: Hot topics
Chairs: Richard J. Traystman and Peter Lipton

  • Richard J. Traystman, PhD
    Introduction / frame
  • Valina L. Dawson, PhD
    NO, PARP
  • Pak H. Chan, PhD
    SOD
  • Patricia D. Hurn, PhD
    Estrogen
  • Michael Moskowitz, Peter Lipton, PhD
    Interactive Discussion


White matter ischemia - unique mechanisms of injury?
Chairs: Mark P. Goldberg and Vladimir Hachinski

  • Mark P. Goldberg, MD
    Introduction / frame: Clinical and research problems in white matter stroke
  • Julio H. Garcia, MD
    Neuropathology of white matter ischemia
  • Stephen A. Back, MD, PhD
    Oligodendrocyte death in the developing brain
  • Peter K. Stys, MD
    Mechanisms of ischemic axonal injury
  • Marie-Germaine Bousser, PhD
    Update on CADASIL: what can we learn about white matter stroke?
  • Vladimir Hachinski, MD
    Interactive Discussion


Inflammation
Chairs: John M. Hallenbeck and Michael Chopp

  • John M. Hallenbeck, MD
    Introduction / frame
  • Mark Fisher, MD
    Infection as a risk factor for stroke
  • Gregory J. del Zoppo, MD
    Extracellular Matrix
  • Chung Y. Hsu, MD, PhD
    Counter Point
  • Michael Chopp, MD
    Interactive Discussion


Plenary lecture:
Free radicals and ischemic brain injury
Bo K. Siesjo, MD, PhD


Dinner Debate:
Heparin should be used to treat patients presenting with acute stroke or stroke-in-evolution
Moderator: Michael N. Diringer, MD

  • Louis R. Caplan, MD (affirmative)
  • William Powers, MD (negative)

 

Saturday, May 9, 1998


Beyond diffusion: imaging measurements of cerebral blood flow and metabolism
Chairs: Marc Fisher and Justin A. Zivin

  • Marc Fisher, MD
    Introduction/frame
  • Jean-Claude Baron, MD
    Cerebral blood flow and metabolism in acute stroke: What PET has taught us
  • E. Mark Haacke, PhD
    Quantifying brain oxygenation with MR
  • Alan C. McLaughlin, PhD
    Quantitative measurement of regional with arterial spin tagging
  • Bruce R. Rosen, MD, PhD
    Measurement of cerebral perfusion by magnetic resonance with intravascular contrast agents
  • Justin A. Zivin , MD, PhD
    Interactive Discussion


Molecular mechanisms of apoptosis
Chairs: Matthew D. Linnik and Michael A. Moskowitz

  • Matthew D. Linnik, PhD
    Introduction/frame
  • Michael O. Hengartner, PhD
    View from the worm
  • Stanley J. Korsmeyer, MD
    Regulation of apoptosis
  • Michael A. Moskowitz, MD
    Interactive Discussion


Delayed neuronal death
Chairs: William A. Pulsinelli and Myron D. Ginsberg

  • William A. Pulsinelli, MD, PhD
    Introduction/frame
  • R. Suzanne Zukin, MD
    Changes in glutamate receptor expression
  • Hannah Monyer, MD
    Regulation of GluRB expression
  • John A. Connor, PhD
    Late changes in neuronal Ca
  • Myron D. Ginsberg, MD
    Interactive Discussion


Cortical reorganization and post-acute stroke treatment
Chairs: Larry B. Goldstein and Alexander W. Dromerick

  • Larry B. Goldstein, MD
    Introduction/frame
  • Randolph J. Nudo, PhD
    Adaptive plasticity in motor cortex
  • Seth P. Finklestein, MD
    Growth factors and recovery
  • Timothy J. Schallert, PhD
    Neuronal events in recovery after injury
  • Alexander W. Dromerick, MD
    Interactive Discussion


Update: Recent Clinical Trials of Drug Treatments for Stroke
Greg Albers, MD


Plenary lecture:
CNS Stem cells: Biology and potential utility for promoting recovery
Fred H. Gage, PhD


Dinner Debate:
MRI is a good endpoint for determining the efficacy of stroke treatment trials
Moderator: Edward M. Manno, MD

  • Steven J. Warach, MD, PhD (affirmative)
  • Joseph P. Broderick, MD (negative)

 

Sunday, May 10, 1998


Directions for the future: where should we go?
Moderators: Dennis W. Choi and Murray Goldstein, DO, MPH)

  • Invited presentations from meeting participants
  • Discussion
  • Panel:
    • Pak H. Chan, PhD
    • Fletcher H. McDowell, MD
    • J.P. Mohr, MD
    • Gary K. Steinberg, MD, PhD
    • Michael D. Walker, MD
    • Justin A. Zivin, MD, PhD

 

Princeton Conference Home Page


This site is provided by the Internet Stroke Center at Washington University in St. Louis.
This site is provided by the Internet Stroke Center at Washington University in St. Louis.
Email comments to: istas@strokecenter.org.